Wave Life Sciences (WVE) Profit After Tax (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.94% |
| Dec 31, 2025 | 1.25% |
| Sep 30, 2025 | -6.70% |
| Jun 30, 2025 | -7.66% |
| Mar 31, 2025 | -260.25% |
| Dec 31, 2024 | 147.35% |
| Sep 30, 2024 | -87.65% |
| Jun 30, 2024 | -4.33% |
| Mar 31, 2024 | -94.13% |
| Dec 31, 2023 | -324.16% |
| Sep 30, 2023 | 134.36% |
| Jun 30, 2023 | 22.99% |
| Mar 31, 2023 | 37.30% |
| Dec 31, 2022 | -12.06% |
| Sep 30, 2022 | 5.55% |
| Jun 30, 2022 | -9.21% |
| Mar 31, 2022 | -8.71% |
| Dec 31, 2021 | -458.35% |
| Sep 30, 2021 | 83.93% |
| Jun 30, 2021 | 8.71% |
| Mar 31, 2021 | -47.50% |
| Dec 31, 2020 | 13.02% |
| Sep 30, 2020 | 18.33% |
| Jun 30, 2020 | 14.67% |
| Mar 31, 2020 | 16.34% |
| Dec 31, 2019 | -11.91% |
| Sep 30, 2019 | -20.94% |
| Jun 30, 2019 | 5.11% |
| Mar 31, 2019 | -16.66% |
| Dec 31, 2018 | -0.68% |
| Sep 30, 2018 | -4.84% |
| Jun 30, 2018 | -1.85% |
| Mar 31, 2018 | -14.44% |
| Dec 31, 2017 | -20.79% |
| Sep 30, 2017 | -3.65% |
| Jun 30, 2017 | -16.60% |
| Mar 31, 2017 | -14.32% |
| Dec 31, 2016 | -5.24% |
| Sep 30, 2016 | -51.62% |
| Jun 30, 2016 | -47.38% |
| Mar 31, 2016 | -10.54% |
| Dec 31, 2015 | -43.82% |
| Sep 30, 2015 | -33.41% |
| Jun 30, 2015 | -6.78% |
| Mar 31, 2015 | -98.11% |
| Dec 31, 2014 | -28.32% |